CHRS vs CTRA · rev $26.6M vs P/E 15, rev $5.46B
Coherus BioSciences Inc (CHRS) versus Coterra Energy Inc (CTRA) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported CTRA revenue for 2024-12-31 was $5.46B. Net income was $1.12B. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
CHRS currently screens at market cap $223.7M. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Not investment advice. Open the CHRS and CTRA stock pages for the full models.
Not investment advice.